Kelly Financial Group’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$335K Buy
2,609
+4
+0.2% +$468 0.07% 72
2026
Q1
$313K Buy
2,605
+5
+0.2% +$577 0.08% 70
2025
Q4
$276K Sell
2,600
-207
-7% -$19.4K 0.07% 72
2025
Q3
$238K Buy
2,807
+17
+0.6% +$1.4K 0.06% 80
2025
Q2
$223K Buy
2,790
+20
+0.7% +$1.59K 0.06% 76
2025
Q1
$249K Buy
2,770
+67
+2% +$6.26K 0.08% 70
2024
Q4
$271K Buy
+2,703
New +$279K 0.1% 62

Other funds holding MRK

Kelly Financial Group's MRK Position: Q2 2026 in Review

Kelly Financial Group increased its Merck (MRK) stake by 0.15% in Q2 2026, buying an estimated $468 and bringing the position to 2,609 shares worth $335K. The position accounts for 0.07% of the portfolio, ranked #72.

Kelly Financial Group first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Kelly Financial Group held 2,609 shares of Merck worth $335K as of Q2 2026.
  • Kelly Financial Group bought 4 Merck shares in Q2 2026, an estimated $468.
  • Merck made up 0.07% of Kelly Financial Group's portfolio in Q2 2026, its #72 holding.
  • Kelly Financial Group first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Kelly Financial Group's 13F filing for Q2 2026, filed 14 Jul 2026.